InVivo BioTech Services
Private Company
Funding information not available
Overview
InVivo BioTech Services is an established, revenue-generating CDMO with over 25 years of experience, headquartered in Berlin, Germany. The company operates a dual business model, offering both contract manufacturing services (antibody/protein production, cell line development) and a proprietary portfolio of research-use-only diagnostic reagents, particularly focused on neuroscience biomarkers. Its core strengths lie in its ISO-certified facilities, deep expertise in mammalian cell culture, and a proven track record of producing components for FDA-approved diagnostic kits, positioning it as a reliable European partner for bioproduction needs.
Technology Platform
Mammalian cell culture-based production platform for monoclonal antibodies and recombinant proteins, coupled with hybridoma and antibody characterization capabilities for reagent development.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CDMO space, competing with large players like Lonza, Catalent, and Samsung Biologics on scale, and with other European niche CDMOs on specialization. In the reagent space, competes with large suppliers like Abcam, Bio-Techne, and Merck, as well as numerous smaller specialty antibody developers.